Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 27, Number 8—August 2021
Dispatch

SARS-CoV-2 Prevalence among Outpatients during Community Transmission, Zambia, July 2020

Jonas Z. HinesComments to Author , Sombo Fwoloshi, Davies Kampamba, Danielle T. Barradas, Dabwitso Banda, James E. Zulu, Adam Wolkon, Samuel Yingst, Mary Adetinuke Boyd, Mpanji Siwingwa, Lameck Chirwa, Muzala Kapina, Nyambe Sinyange, Victor Mukonka, Kennedy Malama, Lloyd B. Mulenga, and Simon Agolory
Author affiliations: US Centers for Disease Control and Prevention, Lusaka, Zambia (J.Z. Hines, D.T. Barradas, A. Wolkon, S. Yingst, M.A. Boyd, S. Agolory); University Teaching Hospital, Lusaka (S. Fwoloshi, D. Kampamba, M. Siwingwa, L. Chirwa, L.B. Mulenga); Zambia Ministry of Health, Lusaka (S. Fwoloshi, K. Malama, L.B. Mulenga); Zambia Field Epidemiology Training Program, Lusaka (D. Banda, J.E. Zulu); Zambia National Public Health Institute, Lusaka (M. Kapina, N. Sinyange, V. Mukonka)

Main Article

Table 2

Severe acute respiratory syndrome coronavirus 2 prevalence measured by PCR, prevalence ratios, and absolute prevalence differences between community members and outpatient participants, stratified by reason for attending the health facility, Zambia, July 2020

Population Prevalence, % (95% CI) Prevalence ratio (95% CI) Absolute difference, % (95% CI)
Community members,† n = 2,990
 7.6 (4.7–10.6)
 Referent
 Referent
Outpatients, n = 1,490
Overall 13.4 (8.3–18.5) 1.8 (1.1–2.9) 5.7 (0.3–11.2)
Fever or respiratory complaint 12.9 (6.6–19.2) 1.7 (0.9–3.0) 5.3 (–1.2 to 11.7)
COVID-19 testing 27.5 (17.7–37.3) 3.6 (2.2–5.9) 19.9 (10.5–29.3)
Other acute medical complaints 10.7 (5.6–15.7) 1.4 (0.8–2.5) 3.0 (–2.4 to 8.4)
Routine health visit 12.5 (4.6–20.3) 1.6 (0.8–3.2) 4.8 (–2.9 to 12.5)
Not specified 15.5 (9.8–21.2) 2.0 (1.2–3.3) 7.9 (2.0–13.8)

*COVID-19, coronavirus disease. †Estimates derived from a cluster-sampled household prevalence survey conducted among community members in the same 6 districts (Kabwe, Livingstone, Lusaka, Nakonde, Ndola, and Solwezi) as in the outpatient prevalence study.

Main Article

Page created: May 14, 2021
Page updated: July 18, 2021
Page reviewed: July 18, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external